High mRNA levels of 17 beta-hydroxysteroid dehydrogenase type 1 correlate with poor prognosis in endometrial cancer

Karlijn M. C. Cornel, Camilla Krakstad, Bert Delvoux, Sofia Xanthoulea, Balazs Jori, Marlies Y. Bongers, Gonda F. J. Konings, Loes F. S. Kooreman, Roy F. P. M. Kruitwagen, Helga B. Salvesen, Andrea Romano*, ENITEC

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)51-57
Number of pages7
JournalMolecular and Cellular Endocrinology
Volume442
Issue numberC
DOIs
Publication statusPublished - 15 Feb 2017

Keywords

  • Endometrial cancer
  • 17 beta-hydroxysteroid-dehydrogenase-type 1
  • 17 beta-hydroxysteroid-dehydrogenase-type 2
  • Steroid sulphatase
  • Estrogen-sulphotransferase
  • Aromatase
  • Estrogens
  • Prognosis
  • BREAST-CANCER
  • ESTROGEN
  • EXPRESSION
  • CARCINOMA
  • 17-BETA-ESTRADIOL
  • OVEREXPRESSION
  • BIOLOGY
  • ALPHA
  • CELLS
  • LINKS

Cite this